This systematic review and network meta-analysis of diagnostic tests, which included 45 studies involving 2,843 patients and 4,263 lesions, indicates that 68Ga-PSMA PET/CT is recommended for the diagnosis of bone metastasis in prostate cancer patients. Here, FOLH1 is linked to prostate cancer.